Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-08-29
2006-08-29
Nguyen, Dave Trong (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C435S069100, C435S006120, C435S091400, C435S325000, C536S023100, C536S024100
Reexamination Certificate
active
07098025
ABSTRACT:
This invention relates to the isolation and cloning of the promoter and other control regions of human PPARγ gene. It provides a method for identifying and screening for agents useful for the treatment of diseases and pathological conditions affected by the level of expression of the PPARγ gene. These agents interact directly or indirectly with the promoter or other control regions of the PPARγ gene.
REFERENCES:
patent: 3845089 (1974-10-01), Henrick
patent: 3884758 (1975-05-01), Green
patent: 4105681 (1978-08-01), Bollag et al.
patent: 4193931 (1980-03-01), Loeliger
patent: 4215215 (1980-07-01), Bollag et al.
patent: 4534979 (1985-08-01), Love et al.
patent: 4648996 (1987-03-01), Aig et al.
patent: 4783549 (1988-11-01), Lang et al.
patent: 4833254 (1989-05-01), Berlin et al.
patent: 4879284 (1989-11-01), Land et al.
patent: 4892940 (1990-01-01), Maignan et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4977276 (1990-12-01), Berlin et al.
patent: 5130333 (1992-07-01), Pan et al.
patent: 5198567 (1993-03-01), Lang et al.
patent: 5219888 (1993-06-01), Katocs, Jr. et al.
patent: 5264372 (1993-11-01), Beaumont et al.
patent: 5304575 (1994-04-01), Beck
patent: 5441971 (1995-08-01), Sohda et al.
patent: 5498696 (1996-03-01), Briggs et al.
patent: 5512683 (1996-04-01), Klaus et al.
patent: 5527690 (1996-06-01), Goldstein et al.
patent: 5654338 (1997-08-01), Metivier
patent: 5683880 (1997-11-01), Kamb
patent: 5686596 (1997-11-01), Mukherjee
patent: 5700836 (1997-12-01), Klaus et al.
patent: 5705167 (1998-01-01), Bernardon et al.
patent: 5707803 (1998-01-01), Lamb et al.
patent: 5726041 (1998-03-01), Chrespi et al.
patent: 5728739 (1998-03-01), Ailhaud et al.
patent: 5763487 (1998-06-01), Bernardon
patent: 5780676 (1998-07-01), Boehm et al.
patent: 5814517 (1998-09-01), Seidel et al.
patent: 5891631 (1999-04-01), Goldstein et al.
patent: 5962731 (1999-10-01), Boehm et al.
patent: 5968908 (1999-10-01), Epstein et al.
patent: 5972881 (1999-10-01), Heyman et al.
patent: 5977125 (1999-11-01), Hibi et al.
patent: 6017924 (2000-01-01), Edwards et al.
patent: 6028052 (2000-02-01), Heyman et al.
patent: 6043279 (2000-03-01), Boehm et al.
patent: 6068976 (2000-05-01), Briggs et al.
patent: 6200802 (2001-03-01), Greene et al.
patent: 6228862 (2001-05-01), Heyman et al.
patent: 6316404 (2001-11-01), Heyman et al.
patent: 6320074 (2001-11-01), Boehm et al.
patent: 6417212 (2002-07-01), Brooks et al.
patent: 6521633 (2003-02-01), Heyman et al.
patent: 6534516 (2003-03-01), Edwards et al.
patent: 6545049 (2003-04-01), Canan-Koch et al.
patent: 6593493 (2003-07-01), Ardecky et al.
patent: 6610696 (2003-08-01), Brooks et al.
patent: 6610883 (2003-08-01), Boehm et al.
patent: 6815168 (2004-11-01), Greene et al.
patent: 6825222 (2004-11-01), Brooks et al.
patent: 2002/0144302 (2002-10-01), Mahfoudl
patent: 2002/0193291 (2002-12-01), Heyman et al.
patent: 2003/0104975 (2003-06-01), Auwerx et al.
patent: 2004/0019072 (2004-01-01), Canan-Koch et al.
patent: 2004/0019090 (2004-01-01), Brooks et al.
patent: 2004/0082623 (2004-04-01), Rochhi et al.
patent: 2004/0106135 (2004-06-01), Mukherjee et al.
patent: 2004/0171689 (2004-09-01), Desreumaux et al.
patent: 2819213 (1987-09-01), None
patent: 0169571 (1986-01-01), None
patent: 0253393 (1988-01-01), None
patent: 0266992 (1988-05-01), None
patent: 0 305 890 (1989-03-01), None
patent: 0 139 417 (1989-07-01), None
patent: 0 569 237 (1993-11-01), None
patent: 0679628 (1995-11-01), None
patent: 0698392 (1996-02-01), None
patent: 0718285 (1996-06-01), None
patent: 0552624 (1997-07-01), None
patent: 0568898 (1998-04-01), None
patent: 0641759 (1998-12-01), None
patent: 0873295 (2003-04-01), None
patent: 1336600 (2003-08-01), None
patent: 0859608 (2004-02-01), None
patent: 1426048 (2004-06-01), None
patent: 2390428 (1978-12-01), None
patent: 2719041 (1995-10-01), None
patent: 2719042 (1995-10-01), None
patent: 2729664 (1996-07-01), None
patent: 2188634 (1987-10-01), None
patent: 2197316 (1988-05-01), None
patent: 05 194 209 (1993-08-01), None
patent: 83/00930 (1983-03-01), None
patent: 89/04489 (1989-05-01), None
patent: 91/01384 (1991-02-01), None
patent: 91/12258 (1991-08-01), None
patent: 92/20642 (1992-11-01), None
patent: 93/09236 (1993-05-01), None
patent: 93/15740 (1993-08-01), None
patent: 93/21146 (1993-10-01), None
patent: 94/12880 (1994-06-01), None
patent: 94/15901 (1994-07-01), None
patent: 94/15902 (1994-07-01), None
patent: 94/17796 (1994-08-01), None
patent: 94/18959 (1994-09-01), None
patent: 95/04036 (1995-02-01), None
patent: 95/07694 (1995-03-01), None
patent: 95/07697 (1995-03-01), None
patent: 95/11974 (1995-05-01), None
patent: 95/23225 (1995-08-01), None
patent: 96/01430 (1996-01-01), None
patent: 96/05165 (1996-02-01), None
patent: 96/13478 (1996-05-01), None
patent: 96/20913 (1996-07-01), None
patent: 96/23884 (1996-08-01), None
patent: 96/29405 (1996-09-01), None
patent: 97/10813 (1997-03-01), None
patent: 97/10819 (1997-03-01), None
patent: 97/12853 (1997-04-01), None
patent: 97/25042 (1997-07-01), None
patent: 97/33881 (1997-09-01), None
patent: 98/05331 (1998-02-01), None
patent: 98/21349 (1998-05-01), None
patent: 98/43081 (1998-10-01), None
patent: 99/05161 (1999-02-01), None
patent: 99/51740 (1999-10-01), None
patent: 02/00611 (2002-01-01), None
patent: 02/094877 (2002-11-01), None
Barnett et al., “Effect of clofibrate on glucose tolerance in maturity onset diabetes,” British Journal of Clinical Pharmacology 4:455-458 (1977).
Berger et al., “Interaction of Glucocorticoid Analogues with the Human Glucocorticoid Receptor,” J. Steroid. Biochem. Molec. Biol. 41: 733-738 (1992).
Boehm et al, “Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids,” J. of Medicinal Chemistry 37(18):2930-41 (1994).
Broach, J.R., “The Yeast of Plasmid 2μ Circle,” In: The Molecular Biology of the Yeast Saccharomyces: Life Cycle and Inheritance, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp. 445-470 (1981).
Carter S.K. et al.(Eds.) Chemotherapy of Cancer, 2nd edition, New York: John Wiley & Sons, Appendix C, pp.364-365 (1981).
Chater et al., “Streptomyces ØC31-Like Phages: Cloning Vectors, Genome Changes and Host Range,” In: Sixth International Symposium on Actinomycetes Biology, Debrecen, Hungary, Aug. 26-30, 1985, pp. 45-54 (1986).
Chemical Abstracts Accession No. 123:281583 for Motojima, K, “Toward the treatment of obesity. Role of PPAR Gamma in Adipogenesis,” Tanpakushitsu Kakusan Koso 40(13):1936-1941 (1995).
Crombie et al., “Creatine kinase activity as an indicator of unopposed estrogen action in the mouse uterus associated with anti-progesterone treatment.” J. Steroid Biochem Mol Biol. 49(2-3)123-9 (1994).
Derwent Abstract for JP 05 194 209A, published Aug. 3, 1993, entitled “Vascular endothelial cell function improvers—contains fenofibrate e.g. isopropyl 2-(p-(p-chloro:benzoyl)phenoxy)-2-methyl propionate”.
Dreborg et al., “The chemistry and standardization of allergens,” Chapter 10 in theHandbook of Experimental Immunology, 4thEd., D.M. Weir et al. (Ed.), Oxford ; Boston : Blackwell Scientific Publications, pp. 10.1-10.27(1986).
Giguere et al., “Functional Domains of the Human Glucocrticoid Receptor,” Cell 46:645-652 (1986).
Giguere et al., “Identification of a receptor for the morphogen retinoic acid,” Nature 330(2):624-629 (1987).
Grundy et al., “Metabolic and Health Complications of Obesity,” Disease-a-Month 36(12):645-696 (1990).
Gryczan, T.J., “Molecular Cloning inBacillus subtilis,” In: The Molecular Biology of the Bacilli, New York: Academic Press, Inc., pp.307-329 (1982).
Ibrahimi et al., “Evidence for a Common Mechanism of Action for Fatty Acids and Thiazolidinedione Antidiabetic Agents on Gene Expression in Preadipose Cells,” Molecular Pharmacology 46:1070-1076 (1994).
Jow, L. and R. Mukherjee, “The human peroxisome proliferator-activated r
Auwerx Johan
Briggs Michael R.
Fajas Lluis
Saladin Regis
Fish & Richardson P.C.
Ligand Pharmaceuticals Incorporated
Marvich Maria
Miskiel Frank J.
Nguyen Dave Trong
LandOfFree
Human peroxisome proliferator activated receptor gamma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human peroxisome proliferator activated receptor gamma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human peroxisome proliferator activated receptor gamma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3624012